Ide-cel or Standard Regimens in Relapsed and Refractory Multiple MyelomaPaula Rodríguez‐Otero, Sergio Giralt, Nizar J. Bahlis et al.|New England Journal of Medicine|2023Cited by 695
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myelomaHolly Lee, Nizar J. Bahlis|Nature Medicine|2023Cited by 305
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Jean‐Luc Harousseau, Shaji Kumar et al.|The Lancet Oncology|2021Cited by 266
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasionPaola Neri, Nizar J. Bahlis|Blood|2011Cited by 161
Tumor Intrinsic Mechanisms of Antigen Escape to Anti-BCMA and Anti-GPRC5D Targeted Immunotherapies in Multiple MyelomaNizar J. Bahlis, Paola Neri|Research Square|2023Cited by 1